๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA ยท Real-Time Price ยท USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST

Lycia Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
4.446.7414.94
Revenue Growth
--54.87%-
Gross Profit
12.936.7414.94
Operating Income
-33.81-39.88-32.53
Net Income
-30.03-36.46-26.5
Earnings Per Share
-2.09-2.59-1.98
EPS Growth
---

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
148.0991.19141.03
Total Debt
3.162.754.77
Net Cash (Debt)
144.9388.44136.25
Net Cash Growth
--35.09%-
Net Cash Per Share
10.096.2710.17

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
-33.75-51.36-29.5
Capital Expenditures
-0.03-0.19-1.27
Free Cash Flow
-33.79-51.56-30.77
Free Cash Flow Growth
---

Margins

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Gross Margin
291.48%100.00%100.00%
Operating Margin
-762.32%-591.57%-217.82%
Pretax Margin
-682.77%-544.56%-177.40%
Profit Margin
-677.16%-540.87%-177.44%
FCF Margin
-761.83%-764.81%-206.03%